Severe Prolonged SGLT2i-induced Euglycemic Diabetic Ketoacidosis Refractory to Standard Therapy and Dialysis: Case Report and Literature Review

Sodium-glucose cotransporter type 2 inhibitors (SGLT2i) are oral hypoglycemic agents that have insulin-independent glucose-lowering effects mediated by increasing the renal excretion of glucose by inhibiting the SGLT2-mediated renal glucose reabsorption. An increasingly recognized complication induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Almazrouei, Raya, Alkindi, Fatima, Alshamsi, Aisha, Dawoud, Tasnim, Chaaban, Ahmad, Rahman, Masood Ur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OMJ 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188737/
https://www.ncbi.nlm.nih.gov/pubmed/35712376
http://dx.doi.org/10.5001/omj.2022.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188737/
https://www.ncbi.nlm.nih.gov/pubmed/35712376
http://dx.doi.org/10.5001/omj.2022.17

Ejemplares similares